Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Times cited: 20
Morbidity and mortality in chronically transfused subjects with Thalassemia and Sickle Cell Disease: A report from the multi-center study of iron overload.
American Journal of Hematology.
Times cited: 83
IGIV-C, a novel intravenous immunoglobulin: Evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.
Thrombosis and Haemostasis.
Times cited: 42